2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
FDA Comment Number : EC27
Submitter : Mr. Anna Hazelton Date & Time: 11/18/2005 02:11:40
Organization : Mr. Anna Hazelton
Category : Drug Industry
Issue Areas/Comments
Please hold the SSRI antidepressant industry accountable for misleading ads calling depression a 'chemical imbalance.' There is very little evidence that this claim is true. In most studies SSRIs have done only slightly better than placebo. These companies should not get away with shady advertising simply because their product is connected with psychiatry, as opposed to any other branch of medicine.

Thanks for your time.